BioSig Technologies, Inc.
BSGM
$4.11
$0.235.93%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -46.09% | 61.21% | 64.43% | 48.98% | 43.53% |
Total Depreciation and Amortization | 73.32% | -60.86% | -46.64% | -35.63% | -33.57% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 83.32% | -67.73% | -79.78% | -8.67% | -34.37% |
Change in Net Operating Assets | 624.90% | -5.78% | 308.19% | -277.56% | -3.36% |
Cash from Operations | 54.46% | 64.87% | 72.52% | 60.91% | 51.21% |
Capital Expenditure | -- | -- | -- | 98.33% | 72.17% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | 671.88% | -- | -- | 98.33% | 72.17% |
Total Debt Issued | -100.00% | -100.00% | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -50.91% | -18.47% | -72.59% | -57.24% | -33.69% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -99.85% | -74.22% |
Cash from Financing | -55.15% | -35.09% | -72.82% | -59.09% | -34.53% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -15.96% | 432.43% | 71.26% | 145.38% | 122.27% |